18 Nov 2026, 09:27
Company UpdateMS
Announcement history available from 1 August 2025
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 18 Nov 2026, 09:27 | Australian Felix Implementation Phase Success | Company Update | MS | 11001 | |
| 12 Nov 2026, 12:38 | Change of Director's Interest Notices x2 | Director Interests | — | 02009 | |
| 11 Nov 2026, 14:04 | Notification of cessation of securities - MEM | Securities Administration | — | 06027 | |
| 9 Nov 2026, 09:13 | Felix Global Commercial Momentum Extends to New Zealand | Company Update | MS | 11001 | |
| 26 Oct 2026, 16:21 | Consolidation/Split - MEM | Securities Administration | — | 06005, 06007 | |
| 26 Oct 2026, 16:16 | Notice of Annual General Meeting/Proxy Form | Meetings & Governance | — | 06005, 08001, 08004 | |
| 14 Oct 2026, 11:25 | Notification regarding unquoted securities - MEM | Securities Administration | — | 06021 | |
| 13 Oct 2026, 09:14 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19001, 19006 | |
| 6 Oct 2026, 08:44 | Initial Director's Interest Notice | Director Interests | — | 02008 | |
| 29 Sept 2026, 09:54 | Proposed issue of securities - MEM | Securities Administration | — | 06013 | |
| 29 Sept 2026, 09:44 | Memphasys receives A$3.5 million from Peters Investments | Capital Raising | MS | 03022, 06005, 08006, 11001 | |
| 25 Sept 2026, 09:35 | Potential Expedited FDA Pathway to US IVF Market | Company Update | MS | 11001 | |
| 21 Sept 2026, 12:12 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 18 Sept 2026, 16:27 | Notification regarding unquoted securities - MEM | Securities Administration | — | 06021 | |
| 18 Sept 2026, 16:22 | Notification regarding unquoted securities - MEM | Securities Administration | — | 06021 | |
| 18 Sept 2026, 16:18 | Application for quotation of securities - MEM | Securities Administration | — | 06020 | |
| 18 Sept 2026, 08:45 | Memphasys Secures European Felix Agreement | Company Update | MS | 11001 | |
| 8 Sept 2026, 09:01 | Memphasys Investor Webinar Presentation - September 2026 | Presentations | — | 03026 | |
| 4 Sept 2026, 11:41 | Investor Webinar Invite | Presentations | — | 14014 | |
| 3 Sept 2026, 09:32 | Felix Registration Achieved in Turkey, Sales Commence | Company Update | MS | 11001 | |
| 2 Sept 2026, 09:30 | Notification of cessation of securities - MEM | Securities Administration | — | 06027 | |
| 1 Sept 2026, 09:29 | EUR526,500 Nordic Agreement Expands Felix European Footprint | Company Update | MS | 11001 | |
| 31 Aug 2026, 18:47 | Appendix 4G and Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 31 Aug 2026, 18:43 | Appendix 4E and 2026 Annual Report | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 | |
| 28 Aug 2026, 08:40 | Felix Early Thai FDA Approval, Commercial Launch Accelerates | Company Update | MS | 11001 | |
| 21 Aug 2026, 17:37 | Results of General Meeting | Meetings & Governance | — | 08003 | |
| 20 Aug 2026, 08:48 | Felix Registration Achieved in Vietnam and Cartridge Order | Company Update | MS | 11001 | |
| 10 Aug 2026, 09:28 | Pivotal Felix Study Receives First Scientific Presentation | Company Update | — | 11001 | |
| 5 Aug 2026, 08:44 | European Commercial Roll-out continues with Poland Agreement | Company Update | MS | 11001 | |
| 22 July 2026, 11:09 | Proposed issue of securities - MEM | Securities Administration | — | 06013 | |
| 22 July 2026, 11:07 | Notice of General Meeting/Proxy Form | Presentations | — | 08004, 08007, 14014, 16001 | |
| 16 July 2026, 09:00 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19004, 19009 | |
| 15 July 2026, 12:04 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 6 July 2026, 16:33 | Memphasys Enters into Consulting Agreement with Director | Company Administration | — | 12008 | |
| 1 July 2026, 08:48 | Exclusive Thailand Commercialisation Agreement Secured | Company Update | MS | 11001 | |
| 26 June 2026, 14:57 | Section 708A Cleansing Statement | Securities Administration | — | 06018 | |
| 26 June 2026, 14:47 | Application for quotation of securities - MEM | Securities Administration | — | 06020 | |
| 25 June 2026, 09:53 | UK Market Entry & Acceleration of Commercial Expansion | Company Update | MS | 11001 | |
| 24 June 2026, 11:59 | Investor Presentation - June 2026 | Presentations | — | 03026 | |
| 23 June 2026, 11:04 | Memphasys Investor Webinar | Presentations | — | 14014 | |
| 18 June 2026, 09:52 | Proposed issue of securities - MEM | Securities Administration | — | 06013 | |
| 18 June 2026, 09:52 | Successful $1.2M Placement and Convertible Note Extended | Capital Raising | MS | 02006, 06003, 09014 | |
| 16 June 2026, 10:08 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 16 June 2026, 09:54 | Pause in Trading | Trading Halt / Suspension | MS | 09005 | |
| 16 June 2026, 09:51 | Memphasys Executes Supply Agreement with Monash IVF Group | Company Update | MS | 11001 | |
| 1 June 2026, 09:21 | South-East Asian Commercialization Agreement Secured | Company Update | MS | 11001 | |
| 27 May 2026, 08:51 | ITL Orders 1000 Felix Cartridges Across MENA Markets | Company Update | MS | 11001 | |
| 25 May 2026, 16:54 | Initial Director's Interest Notice | Director Interests | — | 02008 | |
| 25 May 2026, 16:52 | Final Director's Interest Notice | Director Interests | — | 02010 | |
| 19 May 2026, 08:41 | Change of Chair | Company Update | — | 11001, 12017 |